Clinical trial
Utility of Squamous Cell Carcinoma Antigen (SCCA) in Psoriasis
NCT04308616 is registered in ClinicalTrials.gov with University Hospital, Tours as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Utility of Squamous Cell Carcinoma Antigen (SCCA) in Psoriasis
- Lead sponsor
- University Hospital, Tours
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 20, 2020
- Completion date
- April 27, 2022
- Enrollment
- 51 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.